Cargando…
Correction: Mismatch negativity as EEG biomarker supporting CNS drug development: a transnosographic and translational study
Autores principales: | Loiodice, Simon, Drinkenburg, Wilhelmus H., Ahnaou, Abdallah, McCarthy, Andrew, Viardot, Geoffrey, Cayre, Emilie, Rion, Bertrand, Bertaina-Anglade, Valérie, Mano, Marsel, L’Hostis, Philippe, La Rochelle, Christophe Drieu, Kas, Martien J., Danjou, Philippe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8110967/ https://www.ncbi.nlm.nih.gov/pubmed/33972502 http://dx.doi.org/10.1038/s41398-021-01408-5 |
Ejemplares similares
-
Mismatch negativity as EEG biomarker supporting CNS drug development: a transnosographic and translational study
por: Loiodice, Simon, et al.
Publicado: (2021) -
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Positive Modulator of HGF/MET, Fosgonimeton, in Healthy Volunteers and Subjects with Alzheimer’s Disease: Randomized, Placebo-Controlled, Double-Blind, Phase I Clinical Trial
por: Hua, Xue, et al.
Publicado: (2022) -
Functional Neurophysiological Biomarkers of Early-Stage Alzheimer’s Disease: A Perspective of Network Hyperexcitability in Disease Progression
por: Tok, Sean, et al.
Publicado: (2022) -
Modulation of mGlu2 Receptors, but Not PDE10A Inhibition Normalizes Pharmacologically-Induced Deviance in Auditory Evoked Potentials and Oscillations in Conscious Rats
por: Ahnaou, Abdallah, et al.
Publicado: (2016) -
Beyond the Transnosographic Emphasis on Psychosis: Nosological Perspectives on Schizophrenia and Its Prevention
por: Comparelli, Anna, et al.
Publicado: (2019)